UPDATE ON GENETIC RISK FACTORS FOR THROMBOSIS AND ATHEROSCLEROTIC VASCULAR DISEASE
- 1 December 1998
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 12 (6) , 1193-1209
- https://doi.org/10.1016/s0889-8588(05)70049-6
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Frequency of the 20210 G→A Mutation in the 3′-Untranslated Region of the Prothrombin Gene in 35 Cases of Cerebral Venous ThrombosisStroke, 1998
- Genetic polymorphisms of factor VII are not associated with arterial thrombosisBlood Coagulation & Fibrinolysis, 1998
- Budd-Chiari Syndrome in a Patient Heterozygous for the G20210A Mutation of the Prothrombin GeneThrombosis and Haemostasis, 1998
- Prevalence of the prothrombin gene variant 20210 G→A among patients with myocardial infarctionCardiovascular Research, 1998
- The lysine‐binding function of Lp(a)Clinical Genetics, 1997
- The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic diseaseBritish Journal of Haematology, 1997
- Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′‐untranslated region of the prothrombin geneBritish Journal of Haematology, 1997
- Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels.Journal of Clinical Investigation, 1993
- Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.Journal of Clinical Investigation, 1992
- Vascular lesions in two patients with congenital homocystinuria due to different defects of remethylationJournal of Inherited Metabolic Disease, 1980